Speech biomarker companies for CNS clinical trials (2026)

Companies whose own website offers speech or voice biomarkers for clinical trials or clinical studies, with named CNS indications. Listed in alphabetical order, with no ranking. Published by Cephalgo, a speech biomarker company in Strasbourg, France, which is one of the companies listed. To add or correct a row, write to contact@cephalgo.com.

Last checked: 18 November 2026 · Alphabetical order, no ranking

The companies

Who offers speech biomarkers for CNS trials

Country, offer and named indications as each company states them on its own website. Follow the source link to check a row.

CompanyCountryWhat they publicly offerIndications they nameSource
acceXibleSpainUrdulizSpeech-based assessments for clinical trial pre‑screening, longitudinal monitoring and digital endpoints.Early cognitive decline, preclinical dementiaaccexible.com/en
Cambridge CognitionWinterlight LabsUnited KingdomCambridgeVoice analysis for trial sponsors: standardised speech samples turned into acoustic and linguistic measures, with automated scoring of verbal cognitive tasks beside CANTAB, on browsers, tablets and smartphones.Alzheimer’s disease, mild cognitive impairment, schizophrenia and psychosis, depression, ALS, frontotemporal dementiaOffer: cambridgecognition.com/voice-analysis; indications: cambridgecognition.com/winterlight-labs-published-papers
Canary SpeechUnited StatesProvo, UtahVoice biomarker technology for clinical trials, from a short audio sample recorded on a smartphone or tablet.Multiple sclerosis, Parkinson’s disease, Huntington’s disease, anxiety, depression, dementiaOffer: canaryspeech.com/solutions/use-cases/clinical-trials; indications: canaryspeech.com/solutions/segment/neurological, canaryspeech.com/about
CephalgoPublisher of this pageFranceStrasbourgSpeech readings on the scale a trial already uses, from recordings already held, site visits or home sessions; also review of recorded rating interviews.Alzheimer’s, Parkinson’s, Huntington’s, ALScephalgo.com/cns
Cumulus NeuroscienceUnited KingdomBelfastA multi-modal platform for CNS clinical studies that measures speech (rate, output and pausing) beside cognition, EEG, mood and sleep, in clinic or at home.Alzheimer’s diseasecumulusneuro.com/neulogiq-platform
ki:elementsGermanySaarbrückenSpeech biomarkers for clinical trials from short spoken tasks by telephone, app or browser, for remote pre‑screening and longitudinal tracking.Alzheimer’s, ALS/MND, Parkinsonian syndromes, major depressive disorder, schizophreniaki-elements.de
KoneksaUnited StatesA digital endpoint platform for clinical trials whose configurable measures include speech and voice biomarkers.Parkinson’s diseaseOffer: koneksahealth.com/clinical-endpoints; indications: koneksahealth.com
LANGawareUnited StatesSpeech and voice biomarker software for mild cognitive impairment, Alzheimer’s disease and depression, offered for clinical trial recruitment and for tracking change over time.Mild cognitive impairment, Alzheimer’s disease, depressionOffer: langaware.com/life-sciences; indications: langaware.com/cognitive-health, langaware.com/mental-health
Linus HealthAural AnalyticsUnited StatesBostonDigital cognitive assessments for clinical trials, including voice-based tasks scored for acoustic, semantic and timing measures.Alzheimer’s disease, mild cognitive impairment, Parkinson’s disease, ALSlinushealth.com/use-cases/for-life-sciences
Modality.AIUnited StatesSan FranciscoA conversational assessment platform for clinical trials that measures speech, facial expression and movement, in clinic or remotely.ALS, Parkinson’s disease, schizophrenia, depression, autismmodality.ai
NovoicUnited KingdomLondonSoftware that assesses cognition from speech, with a dashboard for trial screening and a speech API. Browser-based, on any smart device.Alzheimer’s disease, including early and preclinical stages; mild cognitive impairmentnovoic.com; head office: UK Companies House
RedenlabAustraliaMelbourneSpeech analytics for industry-run clinical trials, in clinic or remote, including virtual trials for Phase 0 to IV studies.Alzheimer’s disease, multiple sclerosis, ALS, frontotemporal dementia, Parkinson’s disease, Huntington’s disease, ataxia, neurodevelopmental disorders, depressionredenlab.com
Videra HealthUnited StatesA clinical trial observation suite that analyses captured video, voice and movement, with digital endpoints co-developed with sponsors.Tardive dyskinesiaviderahealth.com/life-sciences/clinical-trials

Listed: companies whose own website states that they offer speech or voice biomarkers for clinical trials or clinical studies run by sponsors, and that name at least one CNS indication. A product validated only in the company’s own trials does not count, and neither do consumer, telehealth, automotive or contact-centre offers. Where a company has been acquired, it is listed under its current owner with the brand in brackets. Rows use the company’s own words where possible and carry no ranking. Where a website gives no head office, it comes from the national company register. The list may not be complete. To add or correct a row, write to contact@cephalgo.com.

What to ask

What to ask any provider

The same questions apply to every company on this list, Cephalgo included.

  • Which clinical scale does the reading land on?
  • Can it read recordings the trial already holds, as well as site visits and home sessions?
  • What happens when phones or their software change during the study?
  • Which named features sit behind each reading?
  • How is each study language calibrated?
  • Where is the data hosted, and which documents does your QA team receive?
  • How is the work priced, and what does the price include?
  • What evidence is available in your indication and population, and where is it published?
  • How does the provider support regulatory interactions, such as FDA meetings or EMA qualification advice?

Eleven questions to ask, and why each one matters ›

Data protection and hosting

Data protection and hosting

Four points shape how speech is collected and handled in a trial.

  • Speech is health data

    Speech recorded to measure health is a special category of personal data under Article 9 of the GDPR. Sponsors run a data protection impact assessment and sign an Article 28 data processing agreement with the provider.

  • Where data is hosted

    Under Chapter V of the GDPR, a transfer of personal data outside the EU needs a legal basis, such as an adequacy decision or standard contractual clauses. Ask each provider where audio and readings are stored and processed.

  • Studies in the United States

    Sponsors running studies in the United States will ask how a provider handles HIPAA where it applies, and whether its systems meet 21 CFR Part 11 for electronic records and signatures.

  • Many languages in one trial

    Multinational trials often rate the same scale in several languages at once. Speech differs by language, so ask how tasks, quality rules and calibration are set in each study language.

Questions

Speech biomarker companies

Which companies offer speech biomarkers for CNS clinical trials?

Companies whose own website offers speech or voice biomarkers for clinical trials or clinical studies, with named CNS indications, include acceXible (Spain), Cambridge Cognition with Winterlight Labs (United Kingdom), Canary Speech (United States), Cephalgo (France), Cumulus Neuroscience (United Kingdom), ki:elements (Germany), Koneksa (United States), LANGaware (United States), Linus Health with Aural Analytics (United States), Modality.AI (United States), Novoic (United Kingdom), Redenlab (Australia) and Videra Health (United States). Last checked on 18 November 2026.

How was this list made?

Cephalgo published this list and is one of the companies on it. A company is listed when its own website states that it offers speech or voice biomarkers for clinical trials or clinical studies run by sponsors, and names at least one CNS indication. A product validated only in the company’s own trials does not count, and neither do consumer, telehealth, automotive or contact-centre offers. Rows are in alphabetical order, with no ranking. The list may not be complete. To add or correct a row, write to contact@cephalgo.com.

Where is speech data from a trial hosted?

Speech recorded to measure health is health data under Article 9 of the GDPR. Where audio and readings are stored and processed is set by each provider and each contract. Ask every provider where data is hosted and on what legal basis any transfer outside the EU takes place. For studies in the United States, sponsors will also ask how the provider addresses HIPAA and 21 CFR Part 11.

What should a sponsor ask a speech biomarker provider?

Ask which clinical scale the reading lands on, where the audio comes from, what happens when phones or their software change, which named features sit behind each reading, how each language is calibrated, how data is protected, what the price includes, what evidence exists for your indication and population, and how the provider supports regulatory interactions. The full checklist sets out eleven questions and why each one matters.

Planning speech measures in a CNS trial?

Share your scale, countries and any audio you hold, and get a written scope.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.